287 related articles for article (PubMed ID: 32191634)
1. PRMT5 regulates T cell interferon response and is a target for acute graft-versus-host disease.
Snyder KJ; Zitzer NC; Gao Y; Choe HK; Sell NE; Neidemire-Colley L; Ignaci A; Kale C; Devine RD; Abad MG; Pietrzak M; Wang M; Lin H; Zhang YW; Behbehani GK; Jackman JE; Garzon R; Vaddi K; Baiocchi RA; Ranganathan P
JCI Insight; 2020 Apr; 5(8):. PubMed ID: 32191634
[TBL] [Abstract][Full Text] [Related]
2. IL-35 mitigates murine acute graft-versus-host disease with retention of graft-versus-leukemia effects.
Liu Y; Wu Y; Wang Y; Cai Y; Hu B; Bao G; Fang H; Zhao L; Ma S; Cheng Q; Song Y; Liu Y; Zhu Z; Chang H; Yu X; Sun A; Zhang Y; Vignali DA; Wu D; Liu H
Leukemia; 2015 Apr; 29(4):939-46. PubMed ID: 25363669
[TBL] [Abstract][Full Text] [Related]
3. The Ex Vivo Treatment of Donor T Cells with Cosalane, an HIV Therapeutic and Small-Molecule Antagonist of CC-Chemokine Receptor 7, Separates Acute Graft-versus-Host Disease from Graft-versus-Leukemia Responses in Murine Hematopoietic Stem Cell Transplantation Models.
Fowler KA; Li K; Whitehurst CB; Bruce DW; Moorman NJ; Aubé J; Coghill JM
Biol Blood Marrow Transplant; 2019 Jun; 25(6):1062-1074. PubMed ID: 30668984
[TBL] [Abstract][Full Text] [Related]
4. The ex vivo toll-like receptor 7 tolerance induction in donor lymphocytes prevents murine acute graft-versus-host disease.
Zogas N; Karponi G; Iordanidis F; Malasidis S; Paraskevas V; Papadopoulou A; Scouras ZG; Anagnostopoulos A; Yannaki E
Cytotherapy; 2018 Jan; 20(1):149-164. PubMed ID: 29150086
[TBL] [Abstract][Full Text] [Related]
5. Extracellular Vesicles Released from Human Umbilical Cord-Derived Mesenchymal Stromal Cells Prevent Life-Threatening Acute Graft-Versus-Host Disease in a Mouse Model of Allogeneic Hematopoietic Stem Cell Transplantation.
Wang L; Gu Z; Zhao X; Yang N; Wang F; Deng A; Zhao S; Luo L; Wei H; Guan L; Gao Z; Li Y; Wang L; Liu D; Gao C
Stem Cells Dev; 2016 Dec; 25(24):1874-1883. PubMed ID: 27649744
[TBL] [Abstract][Full Text] [Related]
6. Peripheral Blood CD38 Bright CD8+ Effector Memory T Cells Predict Acute Graft-versus-Host Disease.
Khandelwal P; Lane A; Chaturvedi V; Owsley E; Davies SM; Marmer D; Filipovich AH; Jordan MB; Marsh RA
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1215-22. PubMed ID: 25881755
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxicity of Donor Natural Killer Cells to Allo-Reactive T Cells Are Related With Acute Graft-vs.-Host-Disease Following Allogeneic Stem Cell Transplantation.
Sheng L; Mu Q; Wu X; Yang S; Zhu H; Wang J; Lai Y; Wu H; Sun Y; Hu Y; Fu H; Wang Y; Xu K; Sun Y; Zhang Y; Zhang P; Zhou M; Lai B; Xu Z; Gao M; Zhang Y; Ouyang G
Front Immunol; 2020; 11():1534. PubMed ID: 32849519
[No Abstract] [Full Text] [Related]
8. IL-35 inhibits acute graft-versus-host disease in a mouse model.
Zhang XH; Zhou Y; Zhang JM; Zhou SY; Wang M; Feng R; Feng FE; Wang QM; Zhu XL; Zhao XS; Lv M; Kong Y; Chang YJ; Huang XJ
Int Immunopharmacol; 2015 Dec; 29(2):383-392. PubMed ID: 26507167
[TBL] [Abstract][Full Text] [Related]
9. Idiopathic pneumonia syndrome in mice after allogeneic bone marrow transplantation: association between idiopathic pneumonia syndrome and acute graft-versus-host disease.
Liu Q; Ning J; Zhang Y; Wu X; Luo X; Fan Z
Transpl Immunol; 2010 May; 23(1-2):12-7. PubMed ID: 20226241
[TBL] [Abstract][Full Text] [Related]
10. R707, a fully human antibody directed against CC-chemokine receptor 7, attenuates xenogeneic acute graft-versus-host disease.
Fowler KA; Vasilieva V; Ivanova E; Rimkevich O; Sokolov A; Abbasova S; Kim E; Coghill JM
Am J Transplant; 2019 Jul; 19(7):1941-1954. PubMed ID: 30748092
[TBL] [Abstract][Full Text] [Related]
11. Endothelial microparticles delivering microRNA-155 into T lymphocytes are involved in the initiation of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
Zhang R; Wang X; Hong M; Luo T; Zhao M; Shen H; Fang J; Li X; Zang S; Chen P; Nie D; Zheng P; Wu Q; Xia L
Oncotarget; 2017 Apr; 8(14):23360-23375. PubMed ID: 28423578
[TBL] [Abstract][Full Text] [Related]
12. IL-12/IL-18-preactivated donor NK cells enhance GVL effects and mitigate GvHD after allogeneic hematopoietic stem cell transplantation.
Song Y; Hu B; Liu Y; Jin Z; Zhang Y; Lin D; Zhu Y; Lei L; Gong H; Mei Y; Teo HY; Wu D; Liu H
Eur J Immunol; 2018 Apr; 48(4):670-682. PubMed ID: 29282719
[TBL] [Abstract][Full Text] [Related]
13. IL-22 deficiency in donor T cells attenuates murine acute graft-versus-host disease mortality while sparing the graft-versus-leukemia effect.
Couturier M; Lamarthée B; Arbez J; Renauld JC; Bossard C; Malard F; Bonnefoy F; Mohty M; Perruche S; Tiberghien P; Saas P; Gaugler B
Leukemia; 2013 Jul; 27(7):1527-37. PubMed ID: 23399894
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of IL-1 Receptor-Associated Kinase 1 Decreases Murine Acute Graft-versus-Host Disease While Preserving the Graft-versus-Lymphoma Effect.
Gao J; Xu Y; Ma S; Liang Y; Liu C; Shen J; Sun Z; Niu M; Xu K; Pan B
Transplant Cell Ther; 2022 Mar; 28(3):134.e1-134.e10. PubMed ID: 34896653
[TBL] [Abstract][Full Text] [Related]
15. Conditioning with Fludarabine-Busulfan versus Busulfan-Cyclophosphamide Is Associated with Lower aGVHD and Higher Survival but More Extensive and Long Standing Bone Marrow Damage.
He X; Ye Y; Xu X; Wang J; Huang Y; Weng G; Zhang M; Guo K
Biomed Res Int; 2016; 2016():3071214. PubMed ID: 27843940
[TBL] [Abstract][Full Text] [Related]
16. G-CSF-Induced Suppressor IL-10+ Neutrophils Promote Regulatory T Cells That Inhibit Graft-Versus-Host Disease in a Long-Lasting and Specific Way.
Perobelli SM; Mercadante AC; Galvani RG; Gonçalves-Silva T; Alves AP; Pereira-Neves A; Benchimol M; Nóbrega A; Bonomo A
J Immunol; 2016 Nov; 197(9):3725-3734. PubMed ID: 27707998
[TBL] [Abstract][Full Text] [Related]
17. Acute graft-versus-host-like disease induced by transplantation of human activated natural killer cells into SCID mice.
Xun C; Brown SA; Jennings CD; Henslee-Downey PJ; Thompson JS
Transplantation; 1993 Aug; 56(2):409-17. PubMed ID: 8356598
[TBL] [Abstract][Full Text] [Related]
18. PRMT5 Is Required for T Cell Survival and Proliferation by Maintaining Cytokine Signaling.
Tanaka Y; Nagai Y; Okumura M; Greene MI; Kambayashi T
Front Immunol; 2020; 11():621. PubMed ID: 32328070
[TBL] [Abstract][Full Text] [Related]
19. Up-Regulation of alpha4beta7 integrin on peripheral T cell subsets correlates with the development of acute intestinal graft-versus-host disease following allogeneic stem cell transplantation.
Chen YB; Kim HT; McDonough S; Odze RD; Yao X; Lazo-Kallanian S; Spitzer TR; Soiffer R; Antin JH; Ritz J
Biol Blood Marrow Transplant; 2009 Sep; 15(9):1066-76. PubMed ID: 19660719
[TBL] [Abstract][Full Text] [Related]
20. Unique patterns of CD8+ T-cell-mediated organ damage in the Act-mOVA/OT-I model of acute graft-versus-host disease.
Érsek B; Lupsa N; Pócza P; Tóth A; Horváth A; Molnár V; Bagita B; Bencsik A; Hegyesi H; Matolcsy A; Buzás EI; Pós Z
Cell Mol Life Sci; 2016 Oct; 73(20):3935-47. PubMed ID: 27137185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
